Mechanism of Intermittent Fasting in Improving Olanzapine-induced Metabolic Disorders in Mice

doi:10.12300/j.issn.1674-5817.2022.089

Abstract

Abstract:

Objective To explore the beneficial role and potential mechanism of intermittent fasting in olanzapine-induced metabolic disorders. Methods C57BL/6J mice were randomly divided into four groups: Saline + ad libitum (Saline+Ad libitum), Saline + intermittent fasting (Saline +IF), olanzapine administration + ad libitum (Olanzapine+ Ad libitum), and olanzapine administration + intermittent fasting (Olanzapine+IF)， with eight mice in each group. The IF group adopted the 5∶2 scheme, that is, fasting on Monday and Thursday every week, and eating freely in the rest of the time. Ad libitum feeding as the control of intermittent fasting, Saline gavage as the control of olanzapine administration. The experiment lasted for 12 weeks. The differences of body mass, liver mass and epididymal adipose tissue mass were compared between the olanzapine-treated group and the control group after IF intervention. The body fat mass, lean body mass, and visceral fat infiltration of mice were analyzed by nuclear magnetic resonance and HE staining, respectively. Furthermore, the levels of fasting blood glucose, insulin, and insulin resistance index (HOMA-IR) in the process of glucose metabolism were also measured by glucose oxidase method and radioimmunoassay, respectively. The effects of IF on H₂O₂ release and the level of cytochrome C mRNA, a marker related to mitochondrial damage, were detected by ELISA and real-time fluorescence quantitative PCR. Results After 12 weeks of treatment, olanzapine induced a significant increase in body mass, body fat, lean body mass and visceral fat infiltration (P<0.05), as well as fasting blood glucose, insulin, and HOMA-IR (P<0.05); however, IF significantly reduced the above indicators (P<0.05). Further studies showed that the release of H₂O₂ and the expression of Cytochrome C mRNA in adipose tissue of mice after intermittent fasting treatment were significantly decreased (P<0.05). Conclusion Intermittent fasting therapy can alleviate olanzapine-induced metabolic disorders in mice. The underlying mechanism may involve the inhibition of oxidative stress level and the maintenance of mitochondrial functions.

Key words: Intermittent fasting therapy, Obesity, Oxidative stress, Mitochondria, C57BL/6J mice

CLC Number:

Q95-33

Han LI,Xiaorui ZHANG,Chengfang ZHANG. Mechanism of Intermittent Fasting in Improving Olanzapine-induced Metabolic Disorders in Mice[J]. Laboratory Animal and Comparative Medicine, 2023, 43(1): 3-10. DOI: 10.12300/j.issn.1674-5817.2022.089.

Figures/Tables 4

References 20

1	STĘPNICKI P, KONDEJ M, KACZOR A A. Current concepts and treatments of schizophrenia[J]. Molecules, 2018, 23(8): E2087. DOI:10.3390/molecules23082087 .
2	JOHNSEN E, KROKEN R A, LØBERG E M, et al. Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia- spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial[J]. Lancet Psychiatry, 2020, 7(11):945- 954. DOI:10.1016/S2215-0366(20)30341-2 .
3	CHENG Z, YUAN Y B, HAN X, et al. An open-label randomised comparison of aripiprazole, olanzapine and risperidone for the acute treatment of first-episode schizophrenia: eight- week outcomes[J]. J Psychopharmacol, 2019, 33(10):1227- 1236. DOI:10.1177/0269881119872193 .
4	POZNYAK A, GRECHKO A V, POGGIO P, et al. The diabetes mellitus-atherosclerosis connection: the role of lipid and lucose metabolism and chronic inflammation[J]. Int J Mol Sci, 2020, 21(5):1835. DOI:10.3390/ijms21051835 .
5	STANCU I C, CREMERS N, VANRUSSELT H, et al. Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo[J]. Acta Neuropathol, 2019, 137(4):599-617. DOI:10.1007/s00401-018-01957-y .
6	BARRA N G, HENRIKSBO B D, ANHÊ F F, et al. The NLRP3 inflammasome regulates adipose tissue metabolism[J]. Bio chem J, 2020, 477(6):1089-1107. DOI:10.1042/BCJ20190472 .
7	MEYERS A K, ZHU X W. The NLRP3 inflammasome: metabolic regulation and contribution to inflammaging[J]. Cells, 2020, 9 (8):1808. DOI:10.3390/cells9081808 .
8	LIU Q Y, ZHANG D Y, HU D Y, et al. The role of mitochondria in NLRP3 inflammasome activation[J]. Mol Immunol, 2018, 103:115-124. DOI:10.1016/j.molimm.2018.09.010 .
9	MILLS E L, KELLY B, LOGAN A, et al. Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages[J]. Cell, 2016, 167(2):457-470.e13. DOI:10.1016/j.cell.2016.08.064 .
10	ANTONI R, JOHNSTON K L, COLLINS A L, et al. Effects of intermittent fasting on glucose and lipid metabolism[J]. Proc Nutr Soc, 2017, 76(3):361-368. DOI:10.1017/S002966511 6002986 .
11	LIANG B J, LIAO S R, HUANG W X, et al. Intermittent fasting therapy promotes insulin sensitivity by inhibiting NLRP3 in flammasome in rat model[J]. Ann Palliat Med, 2021, 10(5): 5299-5309. DOI:10.21037/apm-20-2410 .
12	HUANG Y Q, WANG Y, WANG H, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study [J]. Lancet Psychiatry, 2019, 6(3):211-224. DOI:10.1016/S2215- 0366(18)30511-X .
13	徐若愚, 李献云. 精神分裂症认知行为治疗的研究进展[J]. 神经疾病与精神卫生, 2022, 22(5):342-346.
	XU R Y, LI X Y. Research progress of cognitive behavioral therapy for schizophrenic[J]. J Neurosci Ment Health, 2022, 22 (5):342-346.
14	CARTERI R B, MENEGASSI L N, FELDMANN M, et al. Inter mittent fasting promotes anxiolytic-like effects unrelated to synaptic mitochondrial function and BDNF support[J]. Behav Brain Res, 2021, 404:113163. DOI:10.1016/j.bbr.2021.113163 .
15	MATTSON M P, LONGO V D, HARVIE M. Impact of intermit tent fasting on health and disease processes[J]. Ageing Res Rev, 2017, 39:46-58. DOI:10.1016/j.arr.2016.10.005 .
16	WU K K L, CHEUNG S W M, CHENG K K Y. NLRP3 inflammasome activation in adipose tissues and its implications on meta bolic diseases[J]. Int J Mol Sci, 2020, 21(11):4184. DOI:10.3390/ ijms21114184 .
17	ROTHMAN S M, GRIFFIOEN K J, WAN R Q, et al.
	Brainderived neurotrophic factor as a regulator of systemic
	and brain energy metabolism and cardiovascular health[J].
	N Y Acad Sci Ann, 2012, 1264(1):49-63. DOI:10.1111/j.1749-6632 .
	2012.06525.x.
18	LONGO V D, MATTSON M P. Fasting: molecular mechanisms and clinical applications[J]. Cell Metab, 2014, 19(2):181-192. DOI:10.1016/j.cmet.2013.12.008 .
19	ZHANG W J, CHEN S J, ZHOU S C, et al. Inflammasomes and fibrosis[J]. Front Immunol, 2021, 12:643149. DOI:10.3389/ fimmu.2021.643149 .
20	KAWAI T, AUTIERI M V, SCALIA R. Adipose tissue inflammation and metabolic dysfunction in obesity[J]. Am J Physiol Cell Physiol, 2021, 320(3): C375-C391. DOI:10.1152/ajpcell.00379.2020 .

[1]	WANG Juan, XU Jiahui, TIAN Yunyuan, ZHANG Mengmeng, LI Min, WANG Siwang, LI Yao. Comparison and Behavioral Observation of Two Female Mice Models of Ulcerative Colitis [J]. Laboratory Animal and Comparative Medicine, 2026, 46(3): 332-343.
[2]	LI Jiafei, ZHANG Zhenhao, WANG Shuo, TIAN Ge, WEN Shuang, YAN Yuxue, CUI Ran, YE Zhen, CUI Yongchun. Effects of Autonomic Neuromodulators on Atrial Electrical Remodeling and Histopathological Changes in a Rat Model of Atrial Fibrillation [J]. Laboratory Animal and Comparative Medicine, 2026, 46(3): 321-331.
[3]	AI Xiufeng, ZHANG Lizong, FANG Mingsun, LÜ Dongying, CHEN Chu, CAI Zhaowei, WANG Dejun. Analysis of Differences in the Intestinal Flora of Rats and Mice after Drinking Chlorinated Water Based on 16S rRNA Sequencing [J]. Laboratory Animal and Comparative Medicine, 2026, 46(3): 437-445.
[4]	WU Xianwen, LIU Lili, CHEN Ye, XU Guoheng. Optimization of Cage-Changing Intervals and Wood Shavings Usage for Mice During the Growth Phase in Breeding Systems [J]. Laboratory Animal and Comparative Medicine, 2026, 46(2): 251-260.
[5]	RONG Wenshuang, NIU Yuanfei, LIU Meiting, YANG Mengyuan, CUI Shuang, MA Lina, FU Yao, WANG Lianmei, CAO Junling. Influence of Antigen Type on the Establishment of an Induced Sjögren Syndrome Mouse Model [J]. Laboratory Animal and Comparative Medicine, 2026, 46(2): 178-190.
[6]	XU Yingtao, WANG Mengmeng, LIN Ping, CHI Haitao, WANG Yi, BAI Ying. Exosomes Treat Ischemic Stroke by Regulation of Ferroptosis Through the NRF2/SLC7A11/GPX4 Pathway in Mice [J]. Laboratory Animal and Comparative Medicine, 2026, 46(1): 20-31.
[7]	LIU Chang, XIANG Xuesong, HE Huihuang, CHEN Xiaoqing, QIU Wenhong. Establishment and Evaluation of an Oxidative Stress Model of Atopic Dermatitis Induced by 2,4-dinitrofluorobenzene [J]. Laboratory Animal and Comparative Medicine, 2026, 46(1): 46-54.
[8]	SONG Mengjiao, SHEN Yidong. Approaches and Application Examples for Studying Mitochondrial Morphology and Function in Caenorhabditis elegans [J]. Laboratory Animal and Comparative Medicine, 2025, 45(6): 726-737.
[9]	CHEN Haotian, LIU Jingnan. Applications and Advances of Drosophila in Research of Obesity and Its Related Metabolic Diseases [J]. Laboratory Animal and Comparative Medicine, 2025, 45(6): 688-704.
[10]	LUO Yifan, ZHANG Zhenwei, MEI Lu, SHI Yeping, XING Yitong, ZHANG Zeqi, LI Chuxin, HAN Chunxia, YANG Pingshun, CHEN Qiusheng. Telocytes-Mediated Effects and Mechanisms of Anointing and Massage Therapy Using Oligopeptide-Herbal Medicine Composite Against Obesity in Rats [J]. Laboratory Animal and Comparative Medicine, 2025, 45(5): 551-560.
[11]	WEI Yanye, SHEN Guo, ZHANG Pengfei, SHI Songping, HU Jiahao, ZHANG Xuzhe, HUA Huiyuan, HUA Guanyang, LU Hongzheng, ZENG Yong, JI Feng, WEI Zhumei. Dynamic Monitoring and Correlation Analysis of General Body Indicators, Blood Glucose, and Blood Lipid in Obese Cynomolgus Monkeys [J]. Laboratory Animal and Comparative Medicine, 2025, 45(1): 30-36.
[12]	Yisu ZHANG, Xinru LIU, Ruojie WU, Rui LIU, Hong OUYANG, Xiaohong LI. Establishment and Evaluation of Mouse Model of Pregnancy Pain-depression Comorbidity Induced by Chronic Unpredictable Stress, Complete Freund's Adjuvant and Formalin [J]. Laboratory Animal and Comparative Medicine, 2024, 44(3): 259-269.
[13]	Min LIANG, Yang GUO, Jinjin WANG, Mengyan ZHU, Jun CHI, Yanjuan CHEN, Chengji WANG, Zhilan YU, Ruling SHEN. Construction of Dmd Gene Mutant Mice and Phenotype Verification in Muscle and Immune Systems [J]. Laboratory Animal and Comparative Medicine, 2024, 44(1): 42-51.
[14]	Huiyan QIN, Huafeng CHEN, Hui YANG, Hailan LUO, Weizhong FU, Qingbo LI, Jiehong ZHANG. The Capacity of Silkworm Cocoon Water to Mitigate the Level of Oxidative Stress in Aged Rats [J]. Laboratory Animal and Comparative Medicine, 2022, 42(5): 393-400.
[15]	LI Zifa, ZHANG Hao, REN Meng, XU Kaiyong, HU Minghui, ZHOU Miaomiao, WANG Kezhou. Protective Effect of Quercetin on Lipid Metabolism Disorder in Mice Livers Caused by Cadmium [J]. Laboratory Animal and Comparative Medicine, 2021, 41(4): 305-312.